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1. INTRODUCTION {#hsr289-sec-0005}
===============

Treatment of patients receiving maintenance hemodialysis is subject to large variations in practice patterns.[1](#hsr289-bib-0001){ref-type="ref"}, [2](#hsr289-bib-0002){ref-type="ref"}, [3](#hsr289-bib-0003){ref-type="ref"}, [4](#hsr289-bib-0004){ref-type="ref"}, [5](#hsr289-bib-0005){ref-type="ref"} Given that such variation is associated with the clinical outcomes of these patients,[4](#hsr289-bib-0004){ref-type="ref"}, [6](#hsr289-bib-0006){ref-type="ref"}, [7](#hsr289-bib-0007){ref-type="ref"} improving the quality of practice is critical to their management. To achieve this, quality indicators (QIs) are used as precise measures of quality. These have been used for patients with various diseases, including end‐stage renal disease (ESRD).[8](#hsr289-bib-0008){ref-type="ref"}, [9](#hsr289-bib-0009){ref-type="ref"} However, while several studies have reported associations between the use of effective QIs and clinical outcomes in hemodialysis patients,[10](#hsr289-bib-0010){ref-type="ref"}, [11](#hsr289-bib-0011){ref-type="ref"}, [12](#hsr289-bib-0012){ref-type="ref"} the methods by which these QIs were established in these studies are not clear, and we cannot, therefore, be sure that their selection was based on scientifically valid methods.

In setting QIs, many have recognized the usefulness of Donabedian\'s framework, which defines quality measurement of health care in three parts: structure, process, and outcome.[13](#hsr289-bib-0013){ref-type="ref"} This framework is sometimes expanded into four parts to include a surrogate outcome.[14](#hsr289-bib-0014){ref-type="ref"} As each part is associated with its own advantages and disadvantages, quality can be precisely measured if the meaning of each part differs according to the aim of the measurement initiative.[14](#hsr289-bib-0014){ref-type="ref"} In addition to variations in types of QIs, there are also differences in the process of developing QIs, for example, in the use of guideline‐based versus Delphi methods. The Delphi method was originally developed to ensure an anonymous consensus to avoid domination by a few experts; however, even this method has some variations.[15](#hsr289-bib-0015){ref-type="ref"} Moreover, although there are many variations in the components of QIs and in their development process, no systematic review of existing QIs for maintenance hemodialysis patients has yet been conducted, unlike the case of other areas such as palliative care,[16](#hsr289-bib-0016){ref-type="ref"} trauma care,[17](#hsr289-bib-0017){ref-type="ref"} and anesthesia.[18](#hsr289-bib-0018){ref-type="ref"}

Here, we conducted a systematic review of QIs for maintenance hemodialysis patients to construct item lists and to identify the pros and cons of existing QIs. Our findings will help improve the future development of QIs.

2. MATERIALS AND METHODS {#hsr289-sec-0006}
========================

This current systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement.[19](#hsr289-bib-0019){ref-type="ref"} The study protocol was not registered in the PROSPERO because some standard methods of the systematic review process (eg, prespecification of the primary outcomes, risk of bias assessment, data synthesis including meta‐analyses, or evidence synthesis using GRADE approach), which should be stated through the registration process in PROSPERO, were not required in this study.

2.1. Literature search {#hsr289-sec-0007}
----------------------

We conducted a systematic literature search of MEDLINE via PubMed, Scopus, the Cochrane Library, and CINAHL, without date limits, on February 26, 2016. Our search strategy is shown in [Text S1](#hsr289-supitem-0002){ref-type="supplementary-material"}. We checked the references of all potential publications to extract the definition and development process of the reported QIs.

2.2. Study selection {#hsr289-sec-0008}
--------------------

We included and excluded publications according to the following criteria: Only English‐written publications were included.Those that described the development process or characteristics of QIs for patients aged ≥18 years who were on maintenance hemodialysis therapy ≥3 months were included. Publications examining patients using special modalities such as nocturnal hemodialysis, home dialysis, and combination therapy with peritoneal dialysis were excluded.Those describing only the QIs that should be achieved on initiation of hemodialysis, such as arteriovenous fistula (AVF) creation during the initiation of hemodialysis, were excluded because these QIs could not be modified during the maintenance hemodialysis phase. These QIs were also excluded from the extracting items for each QI set, which we defined as a set of QIs examined in each included article.Those not describing the rationale behind associations with the QIs were excluded. Those that discussed the rationale, such as that behind the association between the QI and clinical outcomes, but did not cite a reference(s), were included.Those in which the numerators and denominators of the QIs were defined, or could be deduced from the description of the QIs, were included.Those that described indicators with specific goals were included. For example, the target hemoglobin (Hb) level, such as Hb ≥ 10 g/dL, had to be reported when Hb level was a QI.Those describing QIs for primary care settings were excluded.Editorials, letters, comments, case reports, dissertations, and theses were excluded.Four authors (I.T., S.S., N.K., and T.Y.) were divided into two teams, with I.T. and N.K. in one, and S.S. and Y.T. in the other. Each team examined half of the articles identified by the electronic search strategy described above and checked them according to the inclusion/exclusion criteria. The two members of each team reviewed each article independently. Articles that were considered to meet the inclusion criteria were obtained as full articles and independently reassessed for inclusion as described above. In the case of discordance in the selection of an article within one team, one author from the other team assessed its inclusion.

2.3. Data extraction {#hsr289-sec-0009}
--------------------

We used a structured Excel data collection form designed by the authors to independently extract the required data from the included studies. Extracted data included the consensus process used to develop the indicator, references for the indicator, a general description of the items in each QI set, the types of indicators for each item, the data sources used to measure each item, and the clinical practice guidelines supporting each QI. We categorized each indicator into one of four types: structure, process, surrogate outcome, and outcome. We defined structure indicators as hospital or clinical resources such as the number of doctors and nurses. We defined process indicators as those that can only be modified by health care professionals and do not depend on the patient\'s condition, such as the frequency of blood tests and noninvasive procedures. We defined surrogate outcomes and outcomes as patient conditions, with surrogate outcomes represented by clinical signs such as test results that are associated with outcomes. We also categorized each indicator according to the data sources that were necessary to measure that indicator, such as claims data, test results, and medical chart review. We defined claims data as data such as information on a disease, procedure, or prescription.

As this is a systematic review of the literature, approval by the research ethics committee was not required.

3. RESULTS {#hsr289-sec-0010}
==========

3.1. Study selection {#hsr289-sec-0011}
--------------------

Following the removal of duplicate publications (576 from MEDLINE, 713 from Scopus, 68 from the Cochrane Library, and 160 from CINAHL), 1,035 articles were retrieved from the electronic literature search. Two hundred and sixty‐three full‐text articles were selected after title‐abstract review and assessed for eligibility according to the inclusion criteria. Seventy articles were included for data extraction after the following articles were excluded: 7 articles written in languages other than English, 134 articles of unsuitable publication type, 13 articles containing unsuitable target populations, 11 articles that did not use QIs, 19 articles with a lack of rationale, 5 articles with vague denominators and nominators, and 4 articles for not setting specific goals for QIs. The flowchart of the study selection process is shown in Figure [1](#hsr289-fig-0001){ref-type="fig"}, and the references of the included articles are shown in [Text S2](#hsr289-supitem-0003){ref-type="supplementary-material"}. Some QI sets were addressed in several articles. Among the 70 articles selected, 30 used indicators developed by the Centers of Medicare and Medicaid Services\' "End‐Stage Renal Disease (ESRD) Core Indicator Project" and "Clinical Performance Measures (CPM) project," which have now been merged into the CPM project in the United States. Details of the CPM project were described on its website,[20](#hsr289-bib-0020){ref-type="ref"} from which we extracted the associated items. Quality indicator sets implemented by some health care providers, such as Fresenius Medical Care and Davita, were addressed in several articles.[21](#hsr289-bib-0021){ref-type="ref"}, [22](#hsr289-bib-0022){ref-type="ref"} The details of QIs other than those for CPM regarding their developer, consensus process, and references associated with their development are summarized in Table [1](#hsr289-tbl-0001){ref-type="table"}.

![Flowchart of study selection](HSR2-1-e89-g001){#hsr289-fig-0001}

###### 

Development process of quality indicators except for clinical performance measures

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Article                                  Organization                                                                  Consensus process                                                              Reference
  ---------------------------------------- ----------------------------------------------------------------------------- ------------------------------------------------------------------------------ -----------------------------------------
  Patton S et al (1)                       St. Michael Hospital, US                                                      Unknown                                                                        Standards of care or practice guideline

  Armistead N et al (2)                    Mid‐Atlantic renal coalition, US                                              Unknown                                                                        Unknown

  Bogdanski P et al (3)                    St Joseph\'s Health Care, UK                                                  Meeting of the interdisciplinary task force at St Joseph\'s Health Care        Unknown

  Bonucchi D et al (4)                     University Hospital, Modena, Italy                                            Unknown                                                                        Previous studies

  Capelli JP (5)                           Our Lady of Lourdes Medical Center, US                                        Meeting of the quality assessment team at our lady of Lourdes medical center   HCFA case mix indicators

  Coelho AP et al (6)                      National Commission for Monitoring of Dialysis, Portugal                      Unknown                                                                        KDOQI

  Cormier T et al (7)                      Southern Alberta Renal Program, Canada                                        Unknown                                                                        KDOQI

  Diamant MJ et al (8)                     Authors                                                                       Unknown                                                                        Previous studies

  Grangé S et al (9)                       Authors                                                                       Unknown                                                                        KDOQI, EBPG

  Hirth RA et al (10)                      Authors                                                                       Unknown                                                                        KDOQI, CPM

  Kõlvald K et al (11)                     Authors                                                                       Unknown                                                                        EBPG, KDIGO, local guideline

  Lacson E et al (12)                      Fresenius Medical Care North America                                          Unknown                                                                        National guideline

  Lowrie EG (13)                           Authors                                                                       Statistical model:\                                                            Previous studies
                                                                                                                         The indicators associated with 1‐year mortality were selected.                 

  Lynch SK et al (14)                      Authors                                                                       Unknown                                                                        Unknown

  Morsch CM et al (15)                     Authors                                                                       Unknown                                                                        KDOQI, previous studies

  Mozes B et al (16)                       Authors                                                                       Statistical model:\                                                            Previous studies
                                                                                                                         The indicators associated with 1‐year mortality were selected.                 

  Parra E et al (17)                       Authors                                                                       Meeting of four hemodialysis volunteer Spanish centers                         Unknown

  Peter J et al (18)                       Milford Dialysis Unit, US                                                     Unknown                                                                        KDOQI

  Plantinga LC et al (19)                  Authors                                                                       Unknown                                                                        KDOQI

  Plantinga LC et al (20)                  Authors                                                                       Unknown                                                                        KDOQI, CSN guideline, EBPG

  Richards N et al (21)                    Fresenius Medical Care                                                        Unknown                                                                        EBPG

  Saudan P et al (22)                      Authors                                                                       Unknown                                                                        Unknown

  Tan J (23)                               Authors                                                                       Unknown                                                                        Unknown

  Thompson S et al (24)                    Authors                                                                       Unknown                                                                        KDOQI, CSN guideline

  Wazny LD et al (25)                      Authors                                                                       Unknown                                                                        KDOQI, CSN guideline

  Wilson SM et al (26)                     Authors                                                                       Unknown                                                                        Unknown

  Wintz R et al (27)                       PQRI Kidney Associates, US                                                    Unknown                                                                        Unknown

  Benner D et al (28)                      DaVita, US                                                                    Unknown                                                                        Previous studies

  Couchoud C et al (29)                    QUEST                                                                         Unknown                                                                        EBPG

  Di Benedetto A et al (30)                Authors                                                                       Unknown                                                                        EBPG

  Hoar S et al (31)                        Authors                                                                       Unknown                                                                        Previous studies

  Ilumin MP et al (32)                     Primary Nurse Monthly Summary, Canada                                         Unknown                                                                        KDOQI

  Lindberg M et al (33)                    Authors                                                                       Unknown                                                                        Previous studies

  Ludvigsen MS et al (34)                  Authors                                                                       Unknown                                                                        Previous studies

  Marcelli D et al (35)                    Authors                                                                       Unknown                                                                        Unknown

  Ponce P et al (36)                       NephroCare, Portugal                                                          Unknown                                                                        International guidelines

  Saudan P et al (37)                      Authors                                                                       Unknown                                                                        Unknown

  Van Andringa de Kempenaer T et al (38)   Rijnland Hospital, the Netherlands                                            Unknown                                                                        KDOQI, previous studies

  Waeleghem JP et al (39)                  ORPADT, the professional Nephrology Nurses Association of Flanders, Belgium   Unknown                                                                        Unknown

  Yuan CM et al (40)                       Authors                                                                       Unknown                                                                        Unknown
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: CPM, clinical performance measure; KDOQI, kidney disease outcomes quality initiative; EBPG, European best practice guideline; CSN, Canadian society of nephrology; QUEST, quality European studies; ORPADT, the organization of paramedical personnel of the dialysis and transplantation centers. The reference article numbers refer to the list of included articles shown in [Text S2](#hsr289-supitem-0003){ref-type="supplementary-material"}.

3.2. Variations in the development of QI sets {#hsr289-sec-0012}
---------------------------------------------

Most QI sets were developed by experts\' consensus based on international guidelines such as the National Kidney Foundation‐Dialysis Outcomes Quality Initiative (NKF‐DOQI) Clinical Practice Guidelines[23](#hsr289-bib-0023){ref-type="ref"} and the European Best Practice Guidelines (EBPG).[24](#hsr289-bib-0024){ref-type="ref"} In terms of the CPM project, the first 16 QIs were developed based on the NKF‐DOQI Clinical Practice Guidelines. These indicators have been updated in recent expert meetings, and the process is disclosed on their website.[20](#hsr289-bib-0020){ref-type="ref"} Compared to QIs developed according to the CPM project, the selection process for most other QI sets that were developed according to the relevant guidelines and the consensus process of experts\' meetings is unclear, because they have not been published or disclosed in English‐language articles. Although the consensus processes for QIs for CPM have been disclosed, these were qualitative rather than quantitative processes using methods like the Delphi method.

3.3. Characteristics of QI items {#hsr289-sec-0013}
--------------------------------

One hundred one QI items were identified among the included articles after identical indicators with different ideal values had been combined. Characteristics of the QI items referenced by more than one article are summarized in Table [2](#hsr289-tbl-0002){ref-type="table"}. The detailed characteristics of all QI items are shown in Table [S1](#hsr289-supitem-0001){ref-type="supplementary-material"}. The clinical practice guidelines or performance measures supporting the indicators, such as CPM,[20](#hsr289-bib-0020){ref-type="ref"} EBPG,[24](#hsr289-bib-0024){ref-type="ref"} and the clinical practice guideline endorsed by Japanese society of dialysis therapy,[25](#hsr289-bib-0025){ref-type="ref"} are also shown in Table [2](#hsr289-tbl-0002){ref-type="table"}. These items were categorized into 10 areas: anemia, mineral and bone disorder (MBD), dialysis adequacy, vascular access, nutrition, fluid management, diabetes, dyslipidemia, infection, and others. The QIs for anemia, MBD, dialysis adequacy, vascular access, nutrition, and fluid management have been examined in several studies (Table [S1](#hsr289-supitem-0001){ref-type="supplementary-material"}). Most of these indicators were for surrogate outcomes, such as achievement of hemoglobin level, serum calcium level and Kt/V, and maximizing the use of AVF, whereas CPM indicators were predominantly process indicators, such as assessment of iron status, and measurement of serum calcium level and hemodialysis adequacy. In particular, although QIs for nutrition were among the most frequently used, they only assessed surrogate outcomes.

###### 

Characteristics of included quality indicators

  Item                                                                                 Category                            Data Source                  Referenced CPGs and Performance Measures
  ------------------------------------------------------------------------------------ ----------------------------------- ---------------------------- ------------------------------------------
  Anemia                                                                                                                                                
  Achievement of Hb (or Ht) level                                                      Surrogate outcome                   Blood test                   CPM, JSDT, EBPG
  Achievement of Hb (or Ht) level on ESA therapy                                       Surrogate outcome and claims data   Blood test                   CPM, JSDT, EBPG
  Achievement of ferritin level                                                        Surrogate outcome                   Blood test                   JSDT, EBPG
  Achievement of TSAT                                                                  Surrogate outcome                   Blood test                   JSDT, EBPG
  Assessment of iron status                                                            Process                             Claims data or blood test    CPM, JSDT, EBPG
  Use of iron therapy when indicated                                                   Process                             Claims data and blood test   CPM, EBPG
  Use of iron therapy in iron overload                                                 Process                             Claims data and blood test   CPM, EBPG
  Administration of ESA                                                                Process                             Claims data                  CPM, EBPG
  Mineral bone disorder                                                                                                                                 
  Achievement of Ca level                                                              Surrogate outcome                   Blood test                   CPM, JSDT, EBPG
  Achievement of P level                                                               Surrogate outcome                   Blood test                   CPM, JSDT, EBPG
  Achievement of Ca and P product                                                      Surrogate outcome                   Blood test                   CPM,
  Achievement of PTH level                                                             Surrogate outcome                   Blood test                   JSDT, EBPG
  Achievement of ALP level                                                             Surrogate outcome                   Blood test                   
  Measurement of Ca level                                                              Process                             Claims data or blood test    CPM, JSDT
  Measurement of P level                                                               Process                             Claims data or blood test    CPM, JSDT
  Dialysis adequacy                                                                                                                                     
  Achievement of Kt/V                                                                  Surrogate outcome                   Chart review                 CPM, JSDT, EBPG
  Achievement of URR                                                                   Surrogate outcome                   Blood test                   CPM,
  Achievement of Kt                                                                    Surrogate outcome                   Chart review                 
  Measurement of adequacy                                                              Process                             Claims data or blood test    CPM, JSDT, EBPG
  Method of measurement of delivered dose                                              Process                             Chart review                 CPM
  Dialysis time                                                                        Surrogate outcome                   Chart review                 JSDT, EBPG
  Number of dialysis sessions                                                          Process                             Claims data                  
  Vascular access                                                                                                                                       
  Maximizing use of AVF                                                                Surrogate outcome                   Chart review                 CPM, JSDT, EBPG
  Minimizing use of catheter                                                           Surrogate outcome                   Chart review                 CPM, EBPG
  Functional autogenous AVF or referral to vascular surgeon for placement              Surrogate outcome                   Chart review                 CPM
  Catheter vascular access and referred for vascular evaluation for permanent access   Surrogate outcome                   Chart review                 CPM
  Decision‐making by surgeon to maximize placement of autogenous AVF                   Process                             Chart review                 CPM
  Nutrition                                                                                                                                             
  Achievement of albumin level                                                         Surrogate outcome                   Blood test                   CPM, EBPG
  Fluid management                                                                                                                                      
  Blood pressure control                                                               Surrogate outcome                   Chart review                 JSDT
  Intradialytic hypotension                                                            Surrogate outcome                   Chart review                 JSDT, EBPG
  Change in body weight between dialysis sessions                                      Surrogate outcome                   Chart review                 JSDT
  Ultrafiltration rate                                                                 Surrogate outcome                   Chart review                 JSDT
  Dietary sodium reduction advice                                                      Process                             Chart review                 CPM
  Sodium profiling practice for hemodialysis                                           Process                             Chart review                 CPM
  Restriction of dialysate sodium                                                      Process                             Chart review                 CPM
  Periodic assessment of postdialysis weight by nephrologists                          Process                             Chart review                 CPM
  Diabetes                                                                                                                                              
  Measurement of blood sugar status                                                    Process                             Claims data                  CPM
  Dyslipidemia                                                                                                                                          
  Achievement of cholesterol level                                                     Surrogate outcome                   Blood test                   JSDT
  Measurement of lipid status                                                          Process                             Claims data                  CPM
  Infection                                                                                                                                             
  Influenza immunization                                                               Process                             Chart review                 CPM
  Suspected infection                                                                  Surrogate outcome                   Chart review                 CPM
  Clinically established infection                                                     Surrogate outcome                   Chart review                 CPM
  Hemodialysis vascular access‐related infection                                       Surrogate outcome                   Chart review                 CPM,
  Hemodialysis vascular access‐related bacteremia                                      Surrogate outcome                   Chart review                 CPM,
  Hemodialysis catheter‐related infection                                              Surrogate outcome                   Chart review                 CPM
  Hemodialysis catheter‐related bacteremia                                             Surrogate outcome                   Chart review                 CPM
  Hemodialysis arteriovenous graft‐related infection                                   Surrogate outcome                   Chart review                 CPM
  Hemodialysis AVF‐related infection                                                   Surrogate outcome                   Chart review                 CPM
  Clinically established infections resulting in hospitalization                       Outcome                             Chart review                 CPM
  Hemodialysis vascular access‐related infections resulting in hospitalization         Outcome                             Chart review                 CPM
  Hemodialysis catheter‐related infections resulting in hospitalization                Outcome                             Chart review                 CPM
  Others                                                                                                                                                
  Mortality                                                                            Outcome                             Chart review                 
  Hospital admission                                                                   Outcome                             Claim data                   
  Achievement of potassium level                                                       Surrogate outcome                   Blood test                   
  Achievement of bicarbonate level                                                     Surrogate outcome                   Blood test                   
  Water quality test                                                                   Process                             Chart review                 
  Attestation of patient satisfaction survey                                           Process                             Chart review                 CPM
  CAHPS in‐center‐hemodialysis survey                                                  Process                             Chart review                 CPM
  Assessment of health‐related quality of life                                         Process                             Chart review                 CPM

Abbreviations: CPGs, clinical practice guidelines; Hb, hemoglobin; Ht, hematocrit; CPM, clinical performance measure; JSDT, Japanese society of dialysis therapy; EBPG, European best practice guideline; ESA, erythropoietin stimulating agent; TSAT, transferrin saturation; Ca, calcium; P, phosphorus; PTH, parathyroid hormone; ALP, alkaline phosphatase; URR, urea reduction ratio; AVF, arteriovenous fistula; HbA1c, hemoglobin A1c; CRP, C‐reactive protein; CHAPS, consumer assessment of health care providers and systems; HCFA, Health Care Finance Administration. The indicators referenced as CPM include those related to Health Care Finance Administration or Centers for Medicare and Medicaid Services.

3.4. Variations in data resources {#hsr289-sec-0014}
---------------------------------

The data sources used to measure each QI are summarized in Tables [2](#hsr289-tbl-0002){ref-type="table"} and [S1](#hsr289-supitem-0001){ref-type="supplementary-material"}. Quality indicators for anemia and MBD can all be measured using information in claims data or blood tests. In contrast, several QIs for other areas need measurement using a chart review. For example, measurement of Kt/V or ultrafiltration rate requires detailed information such as dialysis time, postdialysis body weight, and ultrafiltrate volume, which can rarely be retrieved from test results or claims data. Furthermore, a chart review is needed to measure QIs for infection due to the need for diagnostic information.

4. DISCUSSION {#hsr289-sec-0015}
=============

We conducted a systematic review and generated an items list of existing QIs for adult maintenance hemodialysis patients to determine the pros and cons associated with their use and to discuss the requirements for the development of future QIs. We evaluated variations in the areas and types of indicators and the associated development processes. We also categorized the source data to measure each item in the QI sets. From the perspective of this information, we then assessed the pros and cons of the existing QIs for maintenance hemodialysis patients.

Most QI sets fell under the following areas: anemia, MBD, dialysis adequacy, vascular access, nutrition, fluid management, and infection. Most of the QIs for these areas measured surrogate outcomes, and in particular, indicators for nutrition comprised only surrogate outcomes. Although outcome indicators are, generally, intuitive and easy to understand, in practice, they often require long‐term observation to detect changes. Furthermore, they often require case‐mix adjustment, because they are easily influenced by a patient\'s condition.[14](#hsr289-bib-0014){ref-type="ref"} In contrast, process indicators are so useful for detecting changes in practice within a short period of time, that those most associated with relevant outcomes have been recommended for the assessment of quality of care.[8](#hsr289-bib-0008){ref-type="ref"}, [14](#hsr289-bib-0014){ref-type="ref"} Additionally, the inclusion of more process indicators may benefit maintenance hemodialysis patients. In particular, as our findings show that indicators of nutrition include only surrogate outcomes, process indicators such as nutritional support should be included.

We found that there were several variations in the development process of QIs for maintenance hemodialysis patients. Most of the QI sets were developed by expert consensus or author definition based on international guidelines. Although there is no gold standard guideline‐based method,[26](#hsr289-bib-0026){ref-type="ref"} the development processes used by the studies included in this review were obscure. Most indicators developed using expert consensus were developed by specific health care providers, and the detailed consensus process was not made publicly available. Of the indicators developed using expert consensus, the development process of CPM developed by Medicare were disclosed in a peer‐reviewed article[27](#hsr289-bib-0027){ref-type="ref"} and on their website.[20](#hsr289-bib-0020){ref-type="ref"} The consensus was achieved by face‐to‐face discussion, and the evaluation was descriptive rather than using a quantitative approach such as the Delphi method. A previous report suggested that a consensus achieved using only a face‐to‐face discussion could be biased toward the opinions of dominant persons or groups, owing to the difficulty in assuring anonymity in such processes.[15](#hsr289-bib-0015){ref-type="ref"} To develop a validated set of QIs, it may be important to clarify the consensus process and to exclude such dominance.

The feasibility of measure indicators may be important in the selection of QI sets. Health care providers reportedly spend large sums of money to report their QIs.[8](#hsr289-bib-0008){ref-type="ref"} Several indicators for maintenance hemodialysis patients extracted in this review, even in pivotal areas such as hemodialysis adequacy and fluid management, require a chart review for measurement. These QIs, therefore, require human resources for measurement, which may place a substantial burden on health care providers. Quality indicator sets for maintenance hemodialysis patients that do not require a chart review are warranted. In recent years, most blood test and claims data have been managed in a database, which allows for the automatic retrieval of information required to measure QIs. Moreover, several types of dialysis management software have been developed to electronically manage individuals\' data during dialysis sessions.[28](#hsr289-bib-0028){ref-type="ref"} The use of this software and data can improve current QI measures that require a chart review.

The present systematic review has several strengths with respect to its impact on the health care of hemodialysis patients and methodology. First, it is the first systematic review to examine QIs for maintenance hemodialysis patients. End‐stage renal disease is a leading area in which QIs have been used for clinical practice and insurance systems.[29](#hsr289-bib-0029){ref-type="ref"} No systematic review of QIs for maintenance hemodialysis patients has been conducted, and the QI sets and their items, as well as the development processes used, have not been reported. Second, the four authors were divided into two teams, which reviewed the articles identified through a systematic literature search. Each member of the two teams reviewed half of the articles, and in the case of disagreement, a member of the other team reviewed the inclusion, which mitigated any potential bias that may have resulted from dominance by one author in the consensus process.

This systematic review also had several minor limitations. First, we included only English‐language publications. Although non--English‐speaking countries have also developed indicators, English‐speaking countries such as the United States, Australia, Canada, and the United Kingdom have led the development of QIs,[18](#hsr289-bib-0018){ref-type="ref"} which suggests that the number of indicators we missed might be small. Second, we excluded QIs used for primary‐care settings. As patients with nondialysis chronic kidney disease (CKD) are often managed in primary care settings, QIs for the nondialysis CKD care phase, such as AVF creation, could have been included for primary‐care settings. However, as we focused on QIs that could be modified with maintenance hemodialysis in the ESRD care phase, and maintenance hemodialysis---which requires special equipment and registered medical specialists---can rarely be conducted in primary‐care settings, we considered that QIs for these settings may not be relevant. Finally, we conducted the systemic literature search without using EMBASE. Although medical subject headings cannot be used in Scopus, it covers most of the literatures in EMBASE,[30](#hsr289-bib-0030){ref-type="ref"} which assures that we minimally missed the indicators from EMBASE. Furthermore, our literature search covered the indicators in nursing practices by conducting the search via CINAHL.

In conclusion, this systematic review provides a detailed overview of the existing QIs for maintenance hemodialysis patients. To date, QIs for various areas have been developed and used for maintenance hemodialysis patients. While these indicators cover important factors associated with maintenance hemodialysis patients, most are surrogate outcome or outcome indicators. In contrast, process indicators, which detect changes in practice to measure quality of care, are sparse. Furthermore, the development processes have rarely been disclosed in detail and some indicators require a chart review for measurement, which limits their use and feasibility. Future development of QIs for maintenance hemodialysis patients should use definitive consensus processes and consider process‐centered indicators, which can be measured automatically using claims data and test results contained in electronic medical records, to improve usability and feasibility.
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